Jpmorgan Chase & Co »

Cytokinetics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 284k 83.49
2023-09-30 $11M 386k 29.46
2023-06-30 $12M 375k 32.62
2023-03-31 $8.5M 240k 35.42
2022-12-31 $14M 311k 45.82
2022-06-30 $9.2M 233k 39.29
2022-03-31 $2.4M 65k 36.82
2021-12-31 $2.4M 54k 45.57
2021-03-31 $582k 25k 23.27
2020-12-31 $642k 30k 21.74
2020-09-30 $4.8M 216k 22.33
2020-06-30 $3.5M 150k 23.57
2020-03-31 $3.6M 306k 11.79
2019-12-31 $1.1M 106k 10.61
2019-09-30 $208k 18k 11.40
2019-06-30 $478k 43k 11.10
2019-03-31 $91k 11k 8.11
2018-12-31 $74k 12k 6.30
2018-09-30 $105k 11k 9.86
2018-06-30 $77k 9.3k 8.25
2018-03-31 $806k 112k 7.17
2017-12-31 $712k 87k 8.15
2016-06-30 $2.8k 280 9.90
2016-03-31 $2.8k 280 9.90
2015-12-31 $2.0k 179 11.17
2013-09-30 $224k 30k 7.56